Linkage between prostate cancer occurrence and Y-chromosomal DYS loci in Malaysian subjects

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 5, 2011, Pages 1265-1268

  Nargesi, Mirsaed Miri ^a   Ismail, Patimah ^a   Razack, Azad Hassan Abdul ^b   Pasalar, Parvin ^c   Nazemi, Ali ^d   Oshkoor, Sima Attaollahi ^a   Amini, Peyman ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Haplotypes; Microsatellite loci; Prostate cancer; Y chromosome

Indexed keywords

EID: 84857983412     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Butler JM, Schoske R, Vallone PM, et al (2002). A Novel multiplex for simultaneous amplification of 20 Y-chromosome STR markers. Forensic Sci Int, 129, 10-24.
2. Camp NJ, Cannon-Albright LA, Farnham JM, et al (2007). Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics. Hum Mol Genet, 16, 1271-1278.
3. Camp NJ, Farnham JM, Cannon Albright LA (2005). Genomic search for prostate cancer predisposition loci in Utah pedigrees. Prostate, 65, 365-374.
4. Carpten J, Nupponen N, Isaacs S, et al (2002). Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet, 30, 181-184.
5. Chambers GK, MacAvoy ES (2000). Microsatellites: consensus and controversy. Comp Biochem Physiol, 126, 455-476.
6. Chun FK, de la Taille A, van Poppel H, et al (2009). Prostate Cancer Gene 3 (PCA3): Development and Internal Validation of a Novel Biopsy Nomogram. Eur Urol, 56, 659-668.
7. Dong X, Wang L, Taniguchi K, et al (2003). Mutations in CHEK2 associated with prostate cancer risk. Am J Hum Genet, 72, 270-80.
8. Edwards SM, Kote-Jarai Z, Meitz J, et al (2003). Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene. Am J Hum Genet, 72, 1-12.
9. Ewis AA, Lee J, Naroda T, et al (2002). Linkage between prostate cancer incidence and different alleles of the human Y-linked tetranucleotide polymorphism DYS19. J Med Invest, 49, 56-60.
10. Ewis AA, Lee J, Naroda T, et al (2006). Prostate cancer incidence varies among males from different Y-chromosome lineages. Prostate Cancer, 9, 303-309.
11. Gusmao L, Butler JM, Carracedo A, et al (2006). DNA Commission of the International Society of Forensic Genetics (ISFG): An update of the recommendations on the use of Y-STRs in forensic analysis. Forensic Sci Int, 157, 187-197.
12. Huang SP, Wu WJ, Chang WS, et al (2004). p53 Codon 72 and p21 Codon 31 Polymorphisms in Prostate Cancer. Cancer Epidemiol Biomarkers Prev, 13, 2217-2224.
13. Kayser M, Brauer S, Schadlich H, et al (2003). Y Chromosome STR haplotypes and the genetic structure of U.S. populations of African, European, and Hispanic ancestry. Genome Res, 13, 624-634.
14. Kayser M, Kittler R, Erler A, et al (2004). A comprehensive survey of human Y-chromosomal microsatellites. Am J Hum Genet, 74, 1183-1197.
15. Kehinde EO, Mojiminiyi OA, Sheikh M, et al (2005). Agespecific reference levels of serum prostate-specific antigen and prostate volume in healthy Arab men. Brit J Urol Int, 96, 308-312.
16. Kim W, Yoo T-K, Kim S-J, et al (2007). Lack of association between Y-chromosomal haplogroups and prostate cancer in the Korean population. PLOS ONE, 2(1), e172. doi:10.1371/journal.pone.0000172.
17. Larson GP, Ding Y, Cheng LS, et al (2005). Genetic Linkage of Prostate Cancer Risk to the Chromosome 3 Region Bearing FHIT. Cancer Res, 65, 805-814.
18. Latil A, Cussenot O, Fournier G, et al (1995). Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer. Clin Cancer Res, 1, 1385-1389.
19. Ntais C, Polycarpou A, Ioannidis JPA (2003a). Association of the CYP17 gene polymorphism with the risk of prostate cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev, 12, 120-126.
20. Ntais C, Polycarpou A, Ioannidis JPA (2003b). Vitamin D receptor gene polymorphisms and risk of prostate cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev, 12, 1395-1402.
21. Nwosu V, Carpten J, Trent JM, et al(2001). Heterogeneity of genetic alterations in prostate cancer: evidence of the complex nature of the disease. Hum Mol Genet, 10, 2313-2318.
22. Paiss T, Worner S, Kurtz F, et al (2003). Linkage of aggressive prostate cancer to chromosome 7q31-33 in German prostate cancer families. Eur J Hum Genet, 11, 17-22.
23. Paracchini S, Pearce CL, Kolonel LN, et al (2003). A Y chromosomal influence on prostate cancer risk: the multiethnic cohort study. J Med Genet, 40, 815-819.
24. Tavtigian SV, Simard J, Teng DH, et al (2001). A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet, 27, 172-180.
25. Underhill PA, Shen P, Lin AA, et al (2000). Y chromosome sequence variation and the history of human populations. Nat Genet, 26, 358-361.
26. Witte JS, Goddard KA, Conti DV, et al (2000). Genomewide scan for prostate cancer-aggressiveness loci. Am J Hum Genet, 67, 92-99.
27. World Cancer Report (2008). World Health Organization (WHO). International Agency for Research on Cancer (IARC).
28. Xu J (2000). Combined analysis of hereditary prostate cancer linkage to 1q24-25: results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics. Am J Hum Genet, 66, 945-957.
29. Xu J, Zheng SL, Komiya A, et al (2002). Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Nat Genet, 32, 321-325.